Skip to main content
. 2012 Jul 4;2012:674324. doi: 10.1155/2012/674324

Table 2.

Outcomes of esomeprazole- and pantoprazole-based triple therapy.

EAC group
(n = 208)
PAC group
(n = 245)
P value
Eradication rate
 Intention-to-treat 72% (150/208) 55% (135/245) <.05
 Per-protocol 91% (150/165) 72% (135/187) <.05
Adverse events 19% (39/208) 17% (42/245) .712
Compliance 87% (181/208) 91% (223/245) .083